High Horn's index score predicts poor outcomes in patients with Clostridium difficile infection

Journal of Hospital Infection

Volumn 79, Issue 1, 2011, Pages 23-26

  Arora, V ^a   Kachroo, S ^b   Ghantoji, S S ^b   DuPont, H L ^a,b,c,d   Garey, K W ^a,b,c  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Clostridium difficile; Horn's index; Infection control; Outcomes; Prospective study

Indexed keywords

BACTERIAL TOXIN; CLOSTRIDIUM DIFFICILE TOXIN; METRONIDAZOLE; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; AGED; ARTICLE; CAUCASIAN; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SEVERITY; ECONOMIC ASPECT; ECONOMIC EVALUATION; FEMALE; HIGH RISK PATIENT; HORN'S INDEX; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT INFECTION; RISK ASSESSMENT; SCORING SYSTEM; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 80051469178     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.04.027     Document Type: Article

References (21)

1. Kelly C.P., LaMont J.T. Clostridium difficile - more difficult than ever. N Engl J Med 2008, 359:1932-1940.
2. Salazar M., Baskin L., Garey K.W., DuPont H.L. Clostridium difficile-related death rates in Texas 1999-2005. J Infect 2009, 59:303-307.
3. Kuijper E.J., Coignard B., Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006, 12(Suppl. 6):2-18.
4. McDonald L.C., Killgore G.E., Thompson A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353:2433-2441.
5. Archibald L.K., Banerjee S.N., Jarvis W.R. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004, 189:1585-1589.
6. Dubberke E.R., Wertheimer A.I. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol 2009, 30:57-66.
7. Dubberke E.R., Reske K.A., Olsen M.A., McDonald L.C., Fraser V.J. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008, 46:497-504.
8. Ghantoji S.S., Sail K., Lairson D.R., DuPont H.L., Garey K.W. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 2010, 74:309-318.
9. Garey K.W., Sethi S., Yadav Y., Dupont H.L. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008, 70:298-304.
10. Horn S.D., Sharkey P.D., Bertram D.A. Measuring severity of illness: homogeneous case mix groups. Med Care 1983, 21:14-30.
11. McFarland L.V., Surawicz C.M., Stamm W.E. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990, 162:678-684.
12. Kyne L., Sougioultzis S., McFarland L.V., Kelly C.P. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002, 23:653-659.
13. Hu M.Y., Katchar K., Kyne L., et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology 2009, 136:1206-1214.
14. McDonald L.C., Coignard B., Dubberke E., Song X., Horan T., Kutty P.K. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007, 28:140-145.
15. Al-Eidan F.A., McElnay J.C., Scott M.G., Kearney M.P. Clostridium difficile-associated diarrhoea in hospitalised patients. J Clin Pharm Ther 2000, 25:101-109.
16. Riley T.V., Codde J.P., Rouse I.L. Increased length of hospital stay due to Clostridium difficile associated diarrhoea. Lancet 1995, 345:455-456.
17. Wilcox M.H., Cunniffe J.G., Trundle C., Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 1996, 34:23-30.
18. Kyne L., Hamel M.B., Polavaram R., Kelly C.P. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002, 34:346-353.
19. Song X., Bartlett J.G., Speck K., Naegeli A., Carroll K., Perl T.M. Rising economic impact of Clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol 2008, 29:823-828.
20. Redelings M.D., Sorvillo F., Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007, 13:1417-1419.
21. Pepin J., Valiquette L., Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005, 173:1037-1042.